Raymond James & Associates’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-163,623
| Closed | -$671K | – | 4085 |
|
|
2022
Q1 | $671K | Sell |
163,623
-1,159
| -0.7% | -$4.75K | ﹤0.01% | 2867 |
|
|
2021
Q4 | $588K | Sell |
164,782
-4,219
| -2% | -$15.1K | ﹤0.01% | 2959 |
|
|
2021
Q3 | $615K | Sell |
169,001
-9,565
| -5% | -$34.8K | ﹤0.01% | 2903 |
|
|
2021
Q2 | $779K | Sell |
178,566
-20,847
| -10% | -$90.9K | ﹤0.01% | 2755 |
|
|
2021
Q1 | $820K | Buy |
199,413
+24,073
| +14% | +$99K | ﹤0.01% | 2634 |
|
|
2020
Q4 | $700K | Sell |
175,340
-1,254
| -0.7% | -$5.01K | ﹤0.01% | 2569 |
|
|
2020
Q3 | $477K | Sell |
176,594
-30,424
| -15% | -$82.2K | ﹤0.01% | 2648 |
|
|
2020
Q2 | $569K | Buy |
207,018
+28,248
| +16% | +$77.6K | ﹤0.01% | 2496 |
|
|
2020
Q1 | $422K | Buy |
178,770
+62,861
| +54% | +$148K | ﹤0.01% | 2527 |
|
|
2019
Q4 | $545K | Buy |
115,909
+74,204
| +178% | +$349K | ﹤0.01% | 2651 |
|
|
2019
Q3 | $140K | Buy |
41,705
+289
| +0.7% | +$970 | ﹤0.01% | 3322 |
|
|
2019
Q2 | $136K | Buy |
41,416
+2,623
| +7% | +$8.61K | ﹤0.01% | 3322 |
|
|
2019
Q1 | $118K | Buy |
38,793
+1,344
| +4% | +$4.09K | ﹤0.01% | 3334 |
|
|
2018
Q4 | $102K | Buy |
+37,449
| New | +$102K | ﹤0.01% | 3278 |
|
|
2018
Q1 | – | Sell |
-11,323
| Closed | -$23K | – | 3465 |
|
|
2017
Q4 | $23K | Hold |
11,323
| – | – | ﹤0.01% | 3251 |
|
|
2017
Q3 | $37K | Buy |
11,323
+1,231
| +12% | +$4.02K | ﹤0.01% | 3201 |
|
|
2017
Q2 | $32K | Buy |
+10,092
| New | +$32K | ﹤0.01% | 3134 |
|